Want to see JP:6039 full AI Analyst Report?
Top Page
Japan Animal Referral Medical Center Co., Ltd.
(6039)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥1,140.00
▼(-2.98% Downside)
Action:Reiterated
Date:08/21/26
The score is primarily driven by strong multi-year revenue and earnings growth, but it is meaningfully held back by cash-generation risk (FY2026 free cash flow turning sharply negative) and higher FY2026 debt. Technicals are neutral-to-soft with the stock still below its longer-term moving averages, while valuation is supportive but not especially cheap.
Positive Factors
Sustained Revenue Growth
Revenue has more than doubled over five fiscal years and still grew about 13% in FY2026. Sustained expansion indicates increasing demand for referral-based advanced animal care and provides operating scale that can support continued earnings growth.
Negative Factors
Volatile Free Cash Flow
The sharp deterioration in free cash flow suggests that expansion spending or working-capital requirements can absorb operating cash. Repeated historical volatility reduces confidence in near-term self-funded growth and may increase reliance on financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Revenue has more than doubled over five fiscal years and still grew about 13% in FY2026. Sustained expansion indicates increasing demand for referral-based advanced animal care and provides operating scale that can support continued earnings growth.
Read all positive factors
Japan Animal Referral Medical Center Co., Ltd. (6039) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥15.10B
Dividend Yield1.15%
Average Volume (3M)24.65K
Price to Earnings (P/E)15.1
Beta (1Y)0.79
Revenue Growth15.68%
EPS Growth49.24%
CountryJP
Employees328
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)64.49
Shares Outstanding14,391,000
10 Day Avg. Volume16,500
30 Day Avg. Volume24,646
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)3.10
Price to Sales (P/S)2.44
P/FCF Ratio-15.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)77.4
Revenue Forecast (FY)¥6.70B
Japan Animal Referral Medical Center Co., Ltd. Business Overview & Revenue Model
Company Description
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized...
How the Company Makes Money
The company primarily makes money by providing fee-based veterinary medical services to referred companion animal patients. Revenue is generated from (1) consultation and examination fees for specialist appointments, (2) diagnostic testing and ima...
Japan Animal Referral Medical Center Co., Ltd. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
71
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.19B | 5.28B | 4.27B | 3.87B | 2.98B |
| Gross Profit | 2.51B | 1.81B | 1.43B | 1.41B | 1.07B |
| EBITDA | 1.74B | 1.29B | 961.39M | 996.73M | 680.27M |
| Net Income | 833.43M | 520.98M | 337.22M | 380.66M | 286.94M |
Balance Sheet | |||||
| Total Assets | 11.31B | 8.75B | 8.77B | 8.58B | 7.11B |
| Cash, Cash Equivalents and Short-Term Investments | 1.59B | 1.11B | 1.34B | 1.92B | 1.07B |
| Total Debt | 5.16B | 3.48B | 3.86B | 3.98B | 3.92B |
| Total Liabilities | 6.43B | 4.61B | 4.96B | 4.87B | 4.60B |
| Stockholders Equity | 4.88B | 4.15B | 3.81B | 3.71B | 2.51B |
Cash Flow | |||||
| Free Cash Flow | -953.45M | 418.70M | -141.26M | 82.62M | -44.14M |
| Operating Cash Flow | 1.40B | 1.37B | 899.78M | 810.92M | 557.57M |
| Investing Cash Flow | -2.49B | -994.38M | -985.86M | -784.07M | -1.43B |
| Financing Cash Flow | 1.58B | -608.03M | -392.32M | 820.59M | 722.09M |
Japan Animal Referral Medical Center Co., Ltd. Technical Analysis
Negative
1175.00
Price Trends
1041.26
Positive
1134.11
Negative
1164.17
Negative
Market Momentum
7.61
Positive
49.50
Neutral
20.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6039, the sentiment is Negative. The current price of 1175 is above the 20-day moving average (MA) of 1044.30, above the 50-day MA of 1041.26, and above the 200-day MA of 1164.17, indicating a neutral trend. The MACD of 7.61 indicates Positive momentum. The RSI at 49.50 is Neutral, neither overbought nor oversold. The STOCH value of 20.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6039.
Japan Animal Referral Medical Center Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
JP:6039
Japan Animal Referral Medical Center Co., Ltd.
1,045.00
190.66
22.32%
JP:9628
San Holdings, Inc. (Japan)
1,375.00
-53.40
-3.74%
Japan Animal Referral Medical Center Co., Ltd. Corporate Events
JARMeC Delivers Double-Digit Profit Growth and Plans Higher Dividend
Aug 14, 2026
Japan Animal Referral Medical Center reported strong results for the three months ended June 30, 2026, with net sales up 11.6% year on year to ¥1,644 million and operating profit surging 35.0% to ¥349 million. Profit attributable to owne...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.